Physicians serve a unique role in society, regularly dealing with matters of life and death, with their main objective being to save lives. But when it comes to a patient becoming palliative, should a doctors mission to save someone’s life change?
Continue reading “Palliative care and decision making”
Antonio is a 49 years young resident of New York City, living with type 2 diabetes. He was diagnosed a little over three years ago after a routine check-up with his primary care physician.
While Antonio wasn’t expecting the diagnosis, it wasn’t a complete shock either, as he had lost his mother to diabetes.
Continue reading “Meet Antonio”
Deliberate, calculated attacks on healthcare facilities have become a routine weapon of war. These assaults kill both patients and health workers, and they devastate already vulnerable health systems. Not to mention they violate the Geneva Conventions.
In 2017, there were at least 701 attacks on hospitals, health workers, patients, and ambulances in 23 countries in conflict around the world. More than 101 health workers and 293 patients and others are reported to have died as a result of these attacks. The 2017 report, compiled by the Safeguarding Health in Conflict Coalition, only includes events that occurred in the context of armed conflicts or situations of severe political volatility.
Continue reading “Effect of Violence on Healthcare”
18 years ago Brazil welcomed the country’s first generic drug registration. According to the National Agency for Sanitary Vigilance Agency (Anvisa), prescription of generic drugs increased 65% from 2015 to 2018. Between February of last year and February of this year, 34% of the 115 million medical prescriptions issued were generic versions.
Continue reading “Prescription of generic drugs”
This year, state lawmakers across the U.S. have introduced an unprecedented 160 bills to stem the rising cost of prescription drugs, and have enacted 37 into law.
States are pursuing a range of strategies to tackle drug costs including
- allowing pharmacists to share lower cost drug options with consumers,
- enacting laws that authorize the wholesale purchase of drugs from Canada,
- and requiring drug manufacturers to provide additional data justifying price increases over specified thresholds.
For the past several years there has been increased interest and activity on legislation that relates to the pricing, payment, and costs associated with prescription drugs. Can more be done?
You can find below what the M3 Global Research community answered to this question.
Let us hear your opinion on this by signing up to receive the Monthly Pulse via email and to take part in paid medical studies.